Related Experiment Video For Cancer bronchique
Updated: Feb 1, 2026

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
[Lung cancer: epidemiology and screening]
Claire Merveilleux du Vignaux1, Sophie Beaucaire-Danel2, Nicolas Girard1
1Service de pneumologie, hôpital Louis-Pradel, groupement hospitalier Est, Lyon (Bron), France.
Abstract:
Lung cancer: epidemiology and screening. The incidence of lung cancer in France is estimated 39 495 cases in 2012. Lung cancer is thus the second cancer in men after prostate cancer, and the third after breast cancer and colorectal cancer in women. Epidemiology of lung cancer is changing, with currently ongoing therapeutic innovation translating into mortality reduction. The main risk factor for lung cancer is tobacco-smoking, alongside genetic, occupational, and professional causes. Diagnosis is made at a metastatic stage for more than half of the patients, with limited survival despite treatment. Conversely, when diagnosed at an early stage, lung cancer is eligible to surgical resection, leading to a survival of more than 85% at 5 years. This leads to discuss the opportunity of screening in smokers.
Related Concept Videos
Introduction to Epidemiology
Causality in Epidemiology
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Confounding in Epidemiological Studies
Bias in Epidemiological Studies
Lung Capacity

